Skip to main content
Equibles
CCEL logo

CCEL · Cryo Cell International Inc · Metrics

Track CCEL — free

Use CCEL with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CCEL.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.71 -0.28 (-7.02%)
Rebalance outlook locked
Market Cap
$32.65M
Shares
8.06M
Volume · Oct 5 13.06K Avg daily vol (3M) 23.09K

CCEL metrics

81 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.99
Market cap
$32.65M

Price action

20 metrics
Price change (1W)
-5.9%
Price change (30D)
-6.3%
Price change (3M)
+19.5%
Price change (6M)
+9.6%
Price change (YTD)
+16.0%
Price change (1Y)
-11.9%
Trailing year
Price change (5Y)
-66.9%
52-week high
$4.57
52-week low
$2.89
Change from 52-week high
-12.7%
Change from 52-week low
+38.1%
Annualized volatility
68.6%
Annualized volatility (3M)
77.2%
Beta
0.4
RSI (14D)
47.5
Price vs SMA 50
+0.5%
Price vs SMA 200
+11.2%
Avg volume (3M)
23,092
Relative volume
0.1
Average dollar volume
$91,090

Company

3 metrics
Sector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
8.06M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
1.2×
reciprocal yield 82.4%
EV / EBITDA
43.3×
reciprocal yield 2.3%
EV / EBIT
—
P / sales
1.0×
reciprocal yield 95.3%
P / book
—
FCF yield
18.7%
TTM · current market cap
Buyback yield
0.2%
P / FCF
5.3
reciprocal yield 18.7%
P / operating cash flow
5.2
reciprocal yield 19.3%
Earnings yield
-7.6%

Historical valuation

8 metrics
P / E historical average (3Y)
104.9×
reciprocal yield 1.0%
P / E historical average (5Y)
61.7×
reciprocal yield 1.6%
EV / revenue historical average (3Y)
1.5×
reciprocal yield 64.6%
EV / revenue historical average (5Y)
1.8×
reciprocal yield 56.8%
EV / EBIT historical average (3Y)
37.7×
reciprocal yield 2.6%
EV / EBIT historical average (5Y)
26.2×
reciprocal yield 3.8%
EV / EBITDA historical average (3Y)
21.6×
reciprocal yield 4.6%
EV / EBITDA historical average (5Y)
15.9×
reciprocal yield 6.3%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
77.9%
Operating margin
-0.3%
Trailing 12 months
Net margin
-7.9%
Gross profit (TTM)
—
Operating profit (TTM)
−$103,776
Net income (TTM)
−$2.47M
Trailing 12 months
Diluted EPS (TTM)
$-0.29
FCF margin
19.6%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-2.31

Growth

11 metrics
Revenue growth YoY
-1.9%
Year over year
Net income growth YoY
+55.9%
Revenue (TTM)
$31.13M
Trailing 12 months
EPS growth YoY
+75.0%
Shares change YoY
-0.9%
Year over year · fewer shares
Revenue CAGR (3Y)
+1.3%
Revenue CAGR (5Y)
+0.3%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
-8.9%

Quality

14 metrics
Return on equity
—
Return on assets
-4.1%
Debt / equity
—
Current ratio
0.7
EBITDA (TTM)
$871,895
Free cash flow (TTM)
$6.11M
Quick ratio
0.7
Interest coverage
-0.1
Net debt / EBITDA
5.9
Return on invested capital
—
Trailing 12 months
Net cash
−$5.12M
Latest balance sheet
Cash & equivalents
$507,302
Total assets
$60.71M
Total debt
$8.28M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$6.32M
Capital expenditures (TTM)
$205,780
R&D (TTM)
$311,951
SG&A (TTM)
$18.95M
Stock compensation (TTM)
$303,136
R&D / revenue
1.0%
Stock compensation / revenue
1.0%

Ownership (13F)

3 metrics
13F filers
12
13F filer change QoQ
+1
Institutional ownership
6.9%

Short interest

3 metrics
Short interest
0.1%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
47 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 862692 CUSIP 228895108 Visit website Investor relations